Literature DB >> 1602337

Blood loss and transfusion in patients with isolated femur fractures.

R Lieurance1, J B Benjamin, W D Rappaport.   

Abstract

A retrospective study of 53 patients with isolated femur fractures was performed to evaluate blood loss and transfusion incidence. Patients with other long bone fractures, abdominal, chest, mediastinal, and vascular injuries were excluded. Twenty-one patients required transfusion during the initial hospitalization averaging 2.5 units PRBCs. Admission hematocrit, preoperative and total EBL were found to be significant variables in determining transfusion. Fracture patterns, classified as high or low energy, were not found to correlate with pre- or intraoperative blood loss, incidence of transfusion, delay to surgery or duration of hospital stay. The estimated blood loss in the study group averaged 1,276 cc, stressing the significance of long bone fractures in trauma patients. Preoperative hemorrhage determined transfusion need in contrast to intraoperative blood loss.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602337     DOI: 10.1097/00005131-199206000-00007

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  2 in total

1.  Reducing routine laboratory tests in patients with isolated extremity fractures: a prospective safety and feasibility study in 246 patients.

Authors:  Raj M Amin; Alexander E Loeb; Erik A Hasenboehler; Adam S Levin; Greg M Osgood; Robert S Sterling; Philip F Stahel; Babar Shafiq
Journal:  Patient Saf Surg       Date:  2019-06-14

2.  Patterns, Management, and Outcome of Traumatic Femur Fracture: Exploring the Experience of the Only Level 1 Trauma Center in Qatar.

Authors:  Syed Imran Ghouri; Mohammad Asim; Fuad Mustafa; Ahad Kanbar; Mohamed Ellabib; Hisham Al Jogol; Mohammed Muneer; Nuri Abdurraheim; Atirek Pratap Goel; Husham Abdelrahman; Hassan Al-Thani; Ayman El-Menyar
Journal:  Int J Environ Res Public Health       Date:  2021-05-31       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.